213 related articles for article (PubMed ID: 26867771)
1. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
[TBL] [Abstract][Full Text] [Related]
2. MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk.
Gansmo LB; Romundstad P; Birkeland E; Hveem K; Vatten L; Knappskog S; Lønning PE
Cancer Med; 2015 Dec; 4(12):1901-7. PubMed ID: 26471763
[TBL] [Abstract][Full Text] [Related]
3. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
Wynendaele J; Böhnke A; Leucci E; Nielsen SJ; Lambertz I; Hammer S; Sbrzesny N; Kubitza D; Wolf A; Gradhand E; Balschun K; Braicu I; Sehouli J; Darb-Esfahani S; Denkert C; Thomssen C; Hauptmann S; Lund A; Marine JC; Bartel F
Cancer Res; 2010 Dec; 70(23):9641-9. PubMed ID: 21084273
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility.
Pedram N; Pouladi N; Feizi MA; Montazeri V; Sakhinia E; Estiar MA
Clin Lab; 2016 Jul; 62(7):1303-1308. PubMed ID: 28164646
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancer.
Wenham RM; Schildkraut JM; McLean K; Calingaert B; Bentley RC; Marks J; Berchuck A
Clin Cancer Res; 2003 Oct; 9(12):4396-403. PubMed ID: 14555511
[TBL] [Abstract][Full Text] [Related]
6. A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer.
Stegeman S; Moya L; Selth LA; Spurdle AB; Clements JA; Batra J
Endocr Relat Cancer; 2015 Apr; 22(2):265-76. PubMed ID: 25670033
[TBL] [Abstract][Full Text] [Related]
7. A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.
Zhang Y; Sturgis EM; Wei P; Liu H; Wang Z; Ma Y; Liu C; Gu KJ; Wei Q; Li G
Mol Carcinog; 2019 Dec; 58(12):2276-2285. PubMed ID: 31513313
[TBL] [Abstract][Full Text] [Related]
8. Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma.
Zhou L; Zhang X; Li Z; Zhou C; Li M; Tang X; Lu C; Li H; Yuan Q; Yang M
PLoS One; 2013; 8(5):e64331. PubMed ID: 23724042
[TBL] [Abstract][Full Text] [Related]
9. Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility.
Liu J; Tang X; Li M; Lu C; Shi J; Zhou L; Yuan Q; Yang M
Breast Cancer Res Treat; 2013 Jul; 140(1):151-7. PubMed ID: 23793604
[TBL] [Abstract][Full Text] [Related]
10. Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy.
Yang Y; Gao W; Ding X; Xu W; Liu D; Su B; Sun Y
Oncotarget; 2017 Mar; 8(10):16313-16324. PubMed ID: 27462918
[TBL] [Abstract][Full Text] [Related]
11. [Endometriosis as a risk factor for ovarian cancer].
Vargas-Hernández VM
Cir Cir; 2013; 81(2):163-8. PubMed ID: 23522320
[TBL] [Abstract][Full Text] [Related]
12. p16(CDKN2) gene polymorphism: association with histologic subtypes of epithelial ovarian cancer in China.
Yan L; Na W; Shan K; Xiao-Wei M; Wei G; Shu-Cheng C
Int J Gynecol Cancer; 2008; 18(1):30-5. PubMed ID: 17466040
[TBL] [Abstract][Full Text] [Related]
13. The role of MDM4 SNP34091 A>C polymorphism in cancer: a meta-analysis on 19,328 patients and 51,058 controls.
Jin X; Zhao W; Zheng M; Zhou P; Niu T
Int J Biol Markers; 2017 Mar; 32(1):e62-e67. PubMed ID: 27646776
[TBL] [Abstract][Full Text] [Related]
14. Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
Hashemi M; Sanaei S; Hashemi SM; Eskandari E; Bahari G
Clin Breast Cancer; 2018 Oct; 18(5):e883-e891. PubMed ID: 29439926
[TBL] [Abstract][Full Text] [Related]
15. MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects.
Xu C; Zhu J; Fu W; Liang Z; Song S; Zhao Y; Lyu L; Zhang A; He J; Duan P
Oncotarget; 2016 Nov; 7(44):71718-71726. PubMed ID: 27687591
[TBL] [Abstract][Full Text] [Related]
16. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
17. The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer.
Heubner M; Wimberger P; Kasimir-Bauer S; Otterbach F; Kimmig R; Siffert W
Anticancer Res; 2009 Aug; 29(8):3449-52. PubMed ID: 19661372
[TBL] [Abstract][Full Text] [Related]
18. Lactase persistence and ovarian carcinoma risk in Finland, Poland and Sweden.
Kuokkanen M; Butzow R; Rasinperä H; Medrek K; Nilbert M; Malander S; Lubinski J; Järvelä I
Int J Cancer; 2005 Oct; 117(1):90-4. PubMed ID: 15880573
[TBL] [Abstract][Full Text] [Related]
19. A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.
Gao F; Xiong X; Pan W; Yang X; Zhou C; Yuan Q; Zhou L; Yang M
PLoS One; 2015; 10(8):e0135647. PubMed ID: 26274820
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Zorn KK; Bonome T; Gangi L; Chandramouli GV; Awtrey CS; Gardner GJ; Barrett JC; Boyd J; Birrer MJ
Clin Cancer Res; 2005 Sep; 11(18):6422-30. PubMed ID: 16166416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
